It came, it's 'Saw,' it will conquer the boxoffice

Annual Halloween splatterfest set to torture 'Dan,' holdovers

Lionsgate's "Saw IV" is sure to cut deeply into its boxoffice competition this weekend when it opens in more than 3,000 locations, but the real question is whether the gore-filled sequel can pump some blood into a recently lifeless fall theatrical season.

Disney's Steve Carell-Juliette Binoche comedy "Dan in Real Life" is the only other wide debutant. A counterprogramming ploy, the PG-13 "Dan" aims to pull in anybody not inclined to see "Saw."

Mercifully, the presence of just two wide entrants could help restore a bit of sanity to a marketplace in which star-filled films have been crushed of late amid a surplus of openers and expansions. Among this weekend's notable expansions, "The Darjeeling Limited" heads north of 700 engagements after playing in 201 venues last weekend, when the Wes Anderson comedy managed a decent per-screen average in toting its 23-day cume to $3.9 million.

As for expectations on the R-rated "Saw," it's worth noting that the opening of each new installment has outperformed its predecessor.

The franchise original bowed during Halloween 2004 with $18.3 million and eventually rung up $55.2 million domestically. A year later, "Saw II" unspooled with $31.7 million en route to a $87 million haul, and last year "Saw III" debuted with $33.6 million and took in $80.2 million overall.

Sony's original "The Grudge" frightfest still ranks as the best horror opener ever, bowing with $39 million during the Oct. 22, 2004, frame.

The biggest audience for horror films is males younger than 25 -- a sizable chunk of the moviegoing public.

"That's the core of our audience, (and) they have been tremendously loyal to the franchise," Lionsgate distribution president Steve Rothenberg said. "We expect them to come out in big numbers this weekend."

Some might dismissively place the "Saw" franchise in what has come to be known as "torture porn," a horror subgenre with waning support. But the popular franchise's third sequel should easily top $25 million, and a bow as high as $35 million is foreseeable if the weekend turns out to be a solid one for moviegoing.

Like its past two predecessors, "Saw IV" was directed by Darren Lynn Bousman. Central character Jigsaw (Tobin Bell) was killed in "Saw III," and "Saw IV's" plot line picks up thereafter.

Meanwhile, "Dan," set for more than 1,700 playdates, is expected to skew considerably older than "Saw IV" and possibly attract good date-crowd business.

"It's about as good a counterprogramming kind of film that anybody can make," Disney distribution president Chuck Viane said. "What I think has been wrong in the market in recent weeks has been the fact that too many of the movies have all been the same movie, so to speak, all being R-rated and such."

"Dan" should appeal to a core base of Carell fans and draw broadly among males and females 18 and up, Viane said.

Saturday sneak previews of "Dan" went well, with more than 90% of patrons rating the film very good or excellent.

Unfortunately, little else went well last weekend.

The No. 1 film, Sony's vampire chiller "30 Days of Night," opened at the low end of expectations, grossing $16 million. The distributor also will be hard-pressed to hang a good hold on the horror film this weekend with "Saw IV" buzzing into the marketplace.

But the "30 Days" bow represented a notable success relative to the dismal debuts of several other openers.

Fox Atomic's sports spoof "The Comebacks" rung up just $5.6 million last weekend, so a 50% drop would see the comedy deliver less than $3 million this frame and potentially tumble from the top 10. Miramax executives claimed satisfaction with the $5.5 million bow for the drama "Gone Baby Gone," written and directed by Ben Affleck, but will they feel that way if its 10-day gross through Sunday comes in at $11 million or less?

New Line's CIA thriller "Rendition," starring Reese Witherspoon and Jake Gyllenhaal, opened with just $4.1 million, so the less said about its longer-term prospects, the better.
comments powered by Disqus